ADVERTISEMENT
Edmonton Watch
How to use weight-loss medication alongside a healthier lifestyle
Novo Nordisk's Canadian patent for weight loss drug Ozempic is set to expire in January 2026. Dr. Justin Ezekowitz discusses generic competitors that could be coming.